Enzo signs marketing deal for cervical cancer test

AP News
Posted: Dec 10, 2009 4:41 PM

Enzo Biochem Inc. said Thursday it signed a marketing deal covering New York and New Jersey with Ikonisys Inc. for a molecular cervical cancer test.

Financial terms were not disclosed. Under the deal, New Haven, Conn.-based Enzo will market Ikonisys' tests.

Enzo provides diagnostic services and makes research products and medical tools.

Shares of Enzo fell 2 cents to $5.54 in afternoon trading.